Hepion Pharmaceuticals, Inc.
HEPA
$0.3247
$0.02729.14%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 86.01% | 53.78% | 72.12% | 78.48% | -62.37% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | 71.11% | -33.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.13% | -121.41% | -292.00% | -32.18% | 2,526.00% |
| Change in Net Operating Assets | 102.28% | 310.84% | -190.26% | -170.07% | -205.41% |
| Cash from Operations | 87.19% | 77.59% | 12.12% | 55.97% | -87.64% |
| Capital Expenditure | -- | -- | -- | -- | 98.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -23,176.92% | -- | -- | 98.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -- | -- | -- | 243.27% |
| Foreign Exchange rate Adjustments | 591.11% | 100.00% | -230.48% | 361.17% | 287.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.75% | 94.50% | 11.88% | 79.50% | 43.46% |